Last updated on August 2019

A Phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of topically applied AG013 for the attenuation of oral mucositis in subjects with cancers of the head and neck receiving concomitant chemoradiation therapy


Brief description of study

A study to assess the safety and efficacy of a topical medication for the weakening of oral mucositis in subjects with cancers of the head and neck receiving concomitant chemo radiation therapy

Clinical Study Identifier: TX209380

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.